Avalon GloboCare announced Thursday that CEO David Jin will unveil the launch of the company’s new commercialization plan for its exosome products at a conference in China.
Dr Jin on Saturday will lead a session on “Application of Stem Cell Exosomes” at the Second International Aesthetic Industry Conference in Chengdu.
Exosomes are powerful messengers released by cells into biofluids like plasma/serum, urine, and saliva. Avalon says exosomes can help fight the progression of certain cancers and act as biomarkers to detect tumors.
Source – Proactive Investors